The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial)

The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial)

Abstract Background Sepsis is still a common critical disease with high morbidity and mortality in intensive care unit. Despite published guidelines for sepsis, development of antibiotic therapy and advanced organ support technologies, the mortality of sepsis patients is still 25% or more. It is nec...

Full description

Bibliographic Details
Main Authors: Zhigang Zhou, Tienan Feng, Yun Xie, Peijie Huang, Hui Xie, Rui Tian, Biyun Qian, Ruilan Wang
Format: Article
Language:English
Published: BMC 2019-09-01
Series:BMC Infectious Diseases
Subjects:
Sepsis
Thrombopoietin
Severe thrombocytopenia
Mortality
Rescue therapy
Online Access:http://link.springer.com/article/10.1186/s12879-019-4388-2

Internet

http://link.springer.com/article/10.1186/s12879-019-4388-2

Similar Items